Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Ebola outbreak rages on in West Africa
• Update on meningococcal B vaccination Steven B. Black, MD
• Ebola confirmed in Port Harcourt, Nigeria, linked to Lagos case
• OIG investigates fraud, abuse with HIV drugs
• HCV recommendations updated to include patients with limited resources
• MSM in Nigeria less likely to engage in HIV care due to anti gay law
• White House orders labs to inventory infectious agents, toxins
• ACIP recommends PCV13 for older adults
• Managing the threat of untreatable gonorrhea Gwenda Hughes, MD; Kevin A. Fenton, MD, PhD, FFPH; Stephanie Chisholm
• To err is human Donald Kaye, MD, MACP
• FDA approves combination HIV treatment
• California trees host fungus deadly to patients with HIV/AIDS
• HIV drug resistance in China linked to long-term ART
• High-dose flu vaccine provided better protection in older adults
• Aspirin use for MI prevention low among people with HIV
• CMV seropositivity linked to cardiovascular events in HIV
• Patient age, norovirus genotype may be related
• Vaccine shows promise against chikungunya
• Access to hand sanitizer in classrooms did not reduce absences
• Antifungal therapy may alter epidemiology of invasive mold infections
• Asymptomatic food handlers common cause of foodborne illness outbreaks
• BCG vaccine protects against TB infection, progression
• Changing focus of HPV vaccine discussion could increase immunization rates
• Clarithromycin use increased risk for cardiac death
• Quality improvement interventions reduced excessive bronchiolitis care
• Diabetes placed patients with CHC at increased risk for cirrhosis, decompensation
• Emphasis on child’s direct benefit increased parents’ intent to vaccinate with MMR
• Giardia infections related to IBS, fatigue 6 years later
• Gut microbiota of premature infants influenced by genetics, gestational age
• Hajj pilgrimage led to acquisition, spread of respiratory infections
• Herpes zoster vaccine continued to protect after chemotherapy
• High levels of pre-existing norovirus antibodies predicts protection from infection
• Highly virulent, drug-resistant P. aeruginosa strain identified in Ohio
• HPV vaccine catch up may be cost-effective up to age 22 years
• Human case of H7N9 in China linked to outbreaks at poultry farm
• ID consult decreased mortality, rehospitalization in transplant recipients
• Imiquimod improved immunogenicity of flu vaccine in older adults
• In patients with penicillin sensitivity, carbapenems may be viable option
• Interactive voice response system improved clinical visits
• Intracellular bacteria may be related to recurrent UTI
• MDA programs alone not enough to control schistosomiasis
• MenC vaccine demonstrates significant, long-lasting herd immunity
• MF59 adjuvanted flu vaccine more protective than nonadjuvanted vaccine
• Minor infections may increase children's risk for stroke
• Monthly treatment reduced risk for malaria in Ugandan children
• Mutated polio virus can resist vaccination
• Nalidixic acid-resistant Salmonella tied to international travel
• Neurologic, neuromuscular comorbidities increase risk for severe ILI complications
• Nontuberculous disease, colonization rates increasing in Taiwan
• Oxygen saturation plus other factors must be considered in bronchiolitis work up
• PCV13 linked to decreased IPD incidence in Denmark
• PPI use increased risk for nontyphoid salmonellosis
• Quality improvement interventions reduced excessive bronchiolitis care
• Receiving ART lowered unprotected sex among people with HIV
• Routine vaccination rates increased, remained stable in 2013
• RSV diagnosis via PCR did not match ICD-9 diagnosis codes
• TB arrived at the New World before Europeans
• Treating MDR-TB increased risk of acquired resistance to second-line drugs
• Umbilical cord samples tested positive for antibacterial agents
• Unnecessary HSV testing, treatment may increase costs, risk
• Xpert test could substantially reduce TB burden in India
• Xpert test may eliminate excess isolation time in TB evaluations
• HIV diagnoses in US declined significantly in past decade
• Exposure to live poultry markets a risk factor for H7N9, other novel viruses
• Rifamycin regimens most effective against latent TB
• HCV therapies may increase Medicare Part D spending by $5.8 billion in 2015
• Merck begins phase 3 study of letermovir
• iPrEx OLE shows PrEP efficacy, adherence
• Challenges with pharmacotherapy of HIV/HCV coinfection Leah Molloy, PharmD
• Selection, timing of vaccines for patients with cancer require careful consideration Debbie Blamble, PharmD, BCOP